News

Testosterone Tx Tied to Worse Cardiac Outcomes

06.11.20131954

Testosterone therapy was associated with a higher risk of adverse outcomes in male veterans undergoing coronary angiography, a study showed.

New Test May Predict Severe High Blood Pressure During Pregnancy

05.11.20131780

High blood pressure affects 6 percent to 8 percent of pregnant women in the United States, according to the National Heart, Lung, and Blood Institute.

Nerve Stimulation in Neck May Reduce Heart Failure Symptoms

01.11.20131879

A multidisciplinary team of experts in heart failure, cardiac arrhythmia, and neurosurgery at The Mount Sinai Hospital are now testing nerve stimulation in the neck as a novel therapy for heart failure patients to potentially help relieve their debilitating symptoms of fatigue, shortness of breath, and heart arrhythmias, while reducing their hospitalizations.

Effects of urate-lowering therapy in hyperuricemia on slowing the progression of renal function: a meta-analysis

31.10.20131930

Uric acid (UA) is generally regarded as an independent risk factor for poor prognosis of patients with kidney disease.

Many Rheumatologists Reluctant to Address Hypertension

30.10.20131886

Fewer than 1 in 3 rheumatologists report discussing hypertension with patients who have uncontrolled blood pressure, despite the fact that those with rheumatoid arthritis are at increased risk for cardiovascular disease compared with the general population and that hypertension is a modifiable risk factor.

Discovery Could Lead to Anti-Clotting Drugs With Less Risk of Bleeding

29.10.20132028

Researchers at the University of Illinois at Chicago have discovered a molecular switch that causes small, beneficial clots that stop bleeding to enlarge further during wound healing.

Inhibiting a Single Protein Could Improve Treatment of Atherosclerosis

28.10.20131809

Researchers of the Spanish research council (Consejo Superior de Investigaciones Cient?ficas, CSIC) and the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have discovered that inhibiting the protein Rcan1 in mice reduces the burden of atherosclerosis, one of the commonest cardiovascular diseases.